Sinovac Biotech Ltd (NASDAQ:SVA)

Delayed Data
As of --
-- -- / --
Today’s Change
|||52-Week Range
Institutional investors purchased a net $6.0 million shares of SVA during the quarter ended March 2019. This may signal that the smart money is gaining interest in this company as the 0.00% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders0.00%
Other institutional0.00%
Individual stakeholders--

Largest Quarterly Institutional

Chart unavailable

Latest Institutional Activity

Top 10 Owners of Sinovac Biotech Ltd

Total value ($)Shares
bought / sold
Vision2020 Wealth Management Corp...0.00%1,362000.00%
Sowell Financial Services LLC0.00%00-11-100.00%
EQIS Capital Management, Inc.0.00%17,8790-17,019-48.77%
Merrill Lynch, Pierce, Fenner & S...0.00%12000.00%
City National Rochdale LLC0.00%408000.00%
CDH Investment Advisory Pte. Ltd.0.00%6,000,0000+6,000,000--
Wells Fargo Clearing Services LLC0.00%1,9100-10-0.52%
Susquehanna Financial Group LLLP0.00%16,430000.00%
NEXT Financial Group, Inc.0.00%16000.00%
Blackstone Alternative Investment...0.00%200000.00%

Top 10 Mutual Funds Holding Sinovac Biotech Ltd

Mutual fundStakeShares
Total value ($)Shares
bought / sold
Fidelity Nasdaq Composite Index F...0.00%27,717000.00%
SPDR Portfolio Emerging Markets E...0.00%63,289000.00%
SPDR S&P Emerging Markets Small C...0.00%67,578000.00%
AST JPMorgan Tactical Preservatio...0.00%3,000000.00%
AST Goldman Sachs Multi Asset Por...0.00%3,000000.00%
SPDR SSgA US Small Cap Low Volati...0.00%30,008000.00%
Blackstone Alternative Multi Stra...0.00%200000.00%
Yorktown Small Cap Fund0.00%74,893000.00%